About us
Management
Géraldine Le Duc, PhD
Chief Executive Officer & Co-Founder
- 30 years of expertise in drugs for radiotherapy and imaging of cancer (Guerbet, INSERM, BNL-USA, ESRF)
- More than 100 scientific publications, 4 patents
- Discovery of the radiosensitization effect of AGuIX®
- PhD in Biomedical Physics
Markus Loeffler, MD & MBA
Chief Medical Officer
- More than 20 years of international leadership experience in oncology (Boehringer Ingelheim, Roche, AAA, Mundipharma EDO)
- Expertise in all stages of research and clinical development from first in human to market
- MD & MBA from INSEAD
Michel Julien, PhD
CMC Director
- Over 20 years of experience in parenteral drug research and development
- Strong expertise in CMC activities from lead candidate selection to manufacturing process validation including management of CMOs
- PhD in Biochemistry
Caroline Cayre
Head of Finance and Administration
- 25+ years spent in Finance & Business administration, including 15 years in international business environment
- Broad industry experience: Audit (PwC), Large international groups (HP), Fast growing SMEs/Start-ups (Aledia)
- French Business School (1995) – Studies abroad (Bath-UK), Certified Coach (Teams & Organizations)
Board of directors
Géraldine Le Duc
CEO & Co-Founder
Hervé Brailly
Chairman
Olivier Tillement
Scientific Advisor & Co-Founder
AGuIX® Inventor, University Professor
Philippe Boucheron
Life Sciences Investor
Bpifrance
Thibaut Roulon
Life Sciences Investor
Bpifrance
Nitza Thomasson
Life Sciences Investor
Omnes
Marc Lebozec
Life Sciences Investor
Arbevel
Célia Hart
Life Sciences Investor
Supernova
Yannick Pletan
Formely Country Medical Director
Roche
Philippe Archinard
Deputy CEO-Innovation & Scientific Partnerships
Institut Mérieux
Partners
